The New Orleans Ernest N. Morial Convention Center is excited to learn that the Annual Meeting of the American Association for Cancer Research (AACR) will return to New Orleans in the years 2016 and 2022. The ACCR has held their event at the New Orleans Ernest N. Morial Convention Center three times, most recently in 2001.
Each AACR event has an anticipated attendance of 12,800, resulting in $32.2 million in economic impact for the New Orleans area. The 12,800 attendees will account for 34,600 room nights and 50 convention center hall days each year.
“We are particularly excited with this announcement as another indicator that New Orleans is re-emerging as a magnet for major medical meetings that it once was,” said Bob Johnson, president/general manager of the New Orleans Ernest N. Morial Convention Center. “This position will be further anchored as the multi-billion dollar Greater New Orleans Bioscience Economic Development District becomes a reality over the next few years, which includes a $90 million state-of-the-art cancer research center that is already
under construction.”
“In the last few months we have hosted eight medical related meetings attracting over 66,000 attendees. New Orleans has a history of successfully hosting medical meetings which now are attracting a larger percentage of international attendees who are particularly fond of New Orleans.”
Underscoring their confidence in New Orleans as a world-class biomedical innovator, the state and federal government have invested more than $2 billion towards the following centers in the 2.4-square-mile Greater New Orleans Biosciences Economic Development District which includes the Louisiana Cancer Research Center, a collaboration of the Louisiana Cancer Research Consortium (LCRC), Louisiana State University Health Sciences Center, Tulane University Health Sciences Center and Xavier University; the BioInnovation Center; the proposed Louisiana Medical Center at New Orleans and the new VA Medical Center, a teaching and research medical complex that will serve both Tulane and Louisiana State University medical schools.
Officials with the New Orleans BioInnovation Center anticipate that this investment in infrastructure will position New Orleans as a leading knowledge center for the U.S. and Latin America and increase its world-class bioscience research and technology development.
